dr. simon on durvalumab for patients with lung cancer
Published 6 years ago • 626 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
0:47
dr. feldman on durvalumab for patients with lung cancer
-
4:43
treating for stage iii nsclc after progression on durvalumab
-
0:55
dr. simon on the impact of immunotherapy agents in nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
5:14
tips for managing nsclc patients on durvalumab therapy
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:13
phase ii study of durvalumab for patients with nsclc
-
8:36
pacific trial: durvalumab for stage 3 nsclc
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
5:59
durvalumab in stage iii nsclc based on performance status
-
1:28
dr. vallieres on postoperative qol in patients with lung cancer
-
6:38
pacific trial of durvalumab for lung cancer
-
3:59
pacific trial of durvalumab for stage iii nsclc
-
6:56
update on durvalumab for metastatic bladder cancer
-
4:25
durvalumab tolerability in non–small cell lung cancer